Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5,071,025
-
Total 13F shares
-
19,185,986
-
Share change
-
+9,724
-
Total reported value
-
$4,578,928,999
-
Put/Call ratio
-
388%
-
Price per share
-
$238.67
-
Number of holders
-
294
-
Value change
-
+$6,461,655
-
Number of buys
-
138
-
Number of sells
-
123
Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q4 2017
As of 31 Dec 2017,
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) was held by
294 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,185,986 shares.
The largest 10 holders included
BlackRock Inc., Vanguard Group Inc, ATLANTA CAPITAL MANAGEMENT CO L L C, ACADIAN ASSET MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, TimesSquare Capital Management, LLC, AMERICAN CENTURY COMPANIES INC, STATE STREET CORP, Hitchwood Capital Management LP, and UBS ASSET MANAGEMENT AMERICAS INC.
This page lists
295
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.